Nucor (NUE) Competitors

In the previous week, Nucor had 8 more articles in the media than ATI. MarketBeat recorded 15 mentions for Nucor and 7 mentions for ATI. ATI's average media sentiment score of 0.56 beat Nucor's score of 0.23 indicating that ATI is being referred to more favorably in the media.

ATI has a net margin of 10.09% compared to Nucor's net margin of 7.99%. ATI's return on equity of 29.27% beat Nucor's return on equity.

ATI currently has a consensus target price of $227.63, indicating a potential upside of 19.63%. Nucor has a consensus target price of $276.07, indicating a potential upside of 15.19%. Given ATI's stronger consensus rating and higher possible upside, equities analysts clearly believe ATI is more favorable than Nucor.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

ATI has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Nucor has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market.

76.5% of Nucor shares are owned by institutional investors. 1.0% of ATI shares are owned by company insiders. Comparatively, 0.6% of Nucor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Nucor had 13 more articles in the media than Cabot. MarketBeat recorded 15 mentions for Nucor and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Nucor's score of 0.23 indicating that Cabot is being referred to more favorably in the news media.

Nucor has a net margin of 7.99% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Nucor's return on equity.

Nucor presently has a consensus price target of $276.07, suggesting a potential upside of 15.19%. Cabot has a consensus price target of $89.00, suggesting a potential upside of 14.00%. Given Nucor's stronger consensus rating and higher probable upside, analysts plainly believe Nucor is more favorable than Cabot.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.6% of Nucor shares are owned by insiders. Comparatively, 3.1% of Cabot shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.4%. Nucor pays out 17.9% of its earnings in the form of a dividend. Cabot pays out 53.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years and Cabot has increased its dividend for 14 consecutive years.

Nucor has higher revenue and earnings than Cabot. Nucor is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Nucor has a beta of 1.84, indicating that its share price is 84% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

In the previous week, Nucor had 7 more articles in the media than Chemours. MarketBeat recorded 15 mentions for Nucor and 8 mentions for Chemours. Nucor's average media sentiment score of 0.23 beat Chemours' score of 0.15 indicating that Nucor is being referred to more favorably in the media.

Nucor currently has a consensus target price of $276.07, suggesting a potential upside of 15.19%. Chemours has a consensus target price of $19.70, suggesting a potential upside of 43.38%. Given Chemours' higher probable upside, analysts clearly believe Chemours is more favorable than Nucor.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor has a net margin of 7.99% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Nucor's return on equity.

76.5% of Nucor shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 0.6% of Nucor shares are held by company insiders. Comparatively, 0.9% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.5%. Nucor pays out 17.9% of its earnings in the form of a dividend. Chemours pays out -18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nucor has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market. Comparatively, Chemours has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

Celanese has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Nucor has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market.

Celanese currently has a consensus price target of $62.60, suggesting a potential upside of 40.66%. Nucor has a consensus price target of $276.07, suggesting a potential upside of 15.19%. Given Celanese's higher probable upside, research analysts plainly believe Celanese is more favorable than Nucor.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

In the previous week, Nucor had 3 more articles in the media than Celanese. MarketBeat recorded 15 mentions for Nucor and 12 mentions for Celanese. Nucor's average media sentiment score of 0.23 beat Celanese's score of 0.09 indicating that Nucor is being referred to more favorably in the news media.

Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.3%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Celanese pays out -1.1% of its earnings in the form of a dividend. Nucor pays out 17.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

98.9% of Celanese shares are held by institutional investors. Comparatively, 76.5% of Nucor shares are held by institutional investors. 0.3% of Celanese shares are held by company insiders. Comparatively, 0.6% of Nucor shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nucor has a net margin of 7.99% compared to Celanese's net margin of -12.04%. Celanese's return on equity of 13.04% beat Nucor's return on equity.